Grifols Shareholder Scranton Clinches Debt Deal With Oaktree

A unit of Scranton Enterprises, a major shareholder of Spanish pharmaceutical company Grifols SA, has refinanced its debt in a deal with Oaktree Capital Management.

“Scranton Plasma BV has signed a new three-year binding agreement to refinance existing indebtedness of the group,” Scranton said in an statement dated July 2. The agreement was signed with Oaktree Capital Management, Scranton Chief Financial Officer Its de Bree said when contacted Bloomberg News Wednesday.

The Scranton refinancing was first reported by Reuters, while El Confidencial reported that the company was in talks with Oaktree.

Read: Grifols CEO Eyes Higher Free Cash Flow, ...